Overview

Clinical Efficacy and Safety of Antazoline in Comparison to Propafenone in Conversion of Paroxysmal Atrial Fibrillation to Sinus Rhythm - a Single Center, Randomized, Double-blinded Study (the AnPro Study).

Status:
Recruiting

Trial end date:
2026-01-01

Target enrollment:

Participant gender:

Summary

The purpose of this randomized, double blind, non-inferiority clinical trial was to compare the clinical efficacy and safety of antazoline with propafenone in the rapid conversion of paroxysmal non-valvular atrial fibrillation to sinus rhythm in patients without heart failure

Phase:

Phase 4

Details

Lead Sponsor:

Centre of Postgraduate Medical Education

Treatments:

Antazoline
Propafenone